DSH2 Strengthens Non-invasive Fibroid Treatment Through HIFU Technology

KUALA LUMPUR, May 14 (Bernama) -- KPJ Healthcare Berhad has strengthened women’s healthcare services at Damansara Specialist Hospital 2 (DSH2) through a strategic collaboration with Delta Medisains (M) Sdn Bhd to advance Southeast Asia’s first Supine High-Intensity Focused Ultrasound (HIFU) programme for non-invasive fibroid treatment.

KPJ Healthcare said the collaboration supports DSH2’s continued efforts to strengthen specialised women’s healthcare services through targeted innovation, clinical capability development and multidisciplinary care, in line with the broader direction of the KPJ Health System (KPJHS).

DSH2 is the first hospital in Southeast Asia to introduce Supine HIFU technology for uterine fibroid treatment, with the face-up approach offering greater patient comfort while maintaining treatment precision.

“Early clinical experience at DSH2 has shown encouraging outcomes for selected HIFU cases, including shorter hospital stays and faster recovery compared to more conventional surgical approaches,” the company said in a statement.

KPJ Healthcare president and managing director Chin Keat Chyuan said advancements in healthcare must go beyond introducing new technologies alone.

“The Supine HIFU programme at DSH2 reflects how targeted innovation can strengthen women’s healthcare services while improving both clinical outcomes and the overall patient experience,” he said.

He said patients today increasingly seek treatment approaches that support faster recovery, less disruption to daily life and care better aligned with their individual needs and circumstances.

“More importantly, innovation must always serve a practical clinical purpose. It should translate into meaningful improvements in healthcare delivery, patient outcomes and the overall quality of care,” he said.

The programme is led by consultant obstetricians and gynaecologists Dr Liew Yen Eit and Dr Haliza Kamarudin, supported by multidisciplinary teams at DSH2 specialising in women’s healthcare services.

KPJ Healthcare said the collaboration marks the beginning of a five-year strategic effort to support the long-term development and adoption of Supine HIFU technology in Malaysia, alongside efforts in medical education, technical expertise development and clinical support across the region.

DSH2 was recently recognised as Specialty Hospital of the Year (Women’s) – Malaysia at the Healthcare Asia Awards 2026.

-- BERNAMA